Krankenhausgesellschaft St. Vincenz mbH
- Address
- Auf Dem Schafsberg, 65549 Limburg, Germany
Krankenhausgesellschaft St. Vincenz mbH - Oncology Research Center
Krankenhausgesellschaft St. Vincenz mbH is a distinguished clinical research facility specializing in advanced oncology therapeutics and innovative cancer treatment protocols. The center demonstrates particular expertise in conducting pivotal trials for hematologic malignancies and gynecologic oncology, focusing on optimizing treatment efficacy while minimizing toxicity for patients with complex cancer diagnoses.
- Advanced stage Hodgkin Lymphoma treatment optimization studies
- Newly diagnosed advanced ovarian, peritoneal, and fallopian tube cancer trials
- Combination therapy approaches using PARP inhibitors and targeted biologics
The research center is actively engaged in comparative effectiveness trials evaluating novel chemotherapy regimens and maintenance strategies. Their portfolio includes investigation of BrECADD and escalated BEACOPP protocols for lymphoma patients, as well as comprehensive studies combining niraparib and bevacizumab with standard platinum-based chemotherapy for patients with newly diagnosed high-grade epithelial ovarian cancer across FIGO stages III and IV, including both upfront surgical and interval debulking approaches.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 1 therapeutic areas and 15 of 17 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 2 by active trials.
- 1AGO Research GmbH1active
lock +1 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Krankenhausgesellschaft St. Vincenz mbH
lock Showing 1 of 3 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of BrECADD Versus Escalated BEACOPP in First-Line Treatment of Advanced Hodgkin Lymphoma: A Randomized Controlled Trial | University Of Cologne | Phase III | Not Recruiting | Jul 2016 | Dec 2024 |
IMP list
lock Showing 1 of 17 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Bevacizumab | 2 | Unknown | 2022-08-31 | 2022-08-31 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.